Prof. Sylvain Lehmann was trained as an M.D. (1991, Strasbourg University, School of Medicine, Fr) and a Ph.D. (1992: Cellular and Molecular Biology). He was the recipient of a Howard Hughes fellowship for physician and spent four years in Washington University, USA as a postdoctoral fellow and a research assistant professor (1993-1996). There he started working on Prion and Alzheimer Disease using cell culture and cell biological tools. From 1997-2002 he was an INSERM Senior Researcher and in 2003 obtained a position of professor of Biochemistry at the Medical School of Montpellier. As a Qualified Medical Biologist/Pathologist from The French National Medical Council (CNOM), his clinical unit at the University Hospital Center (CHU) of Montpellier oversees the biological diagnosis of neurodegenerative disorders and he recently set up a reference Neurological biobank. His laboratory integrates the “Clinical Proteomics Platform” of the CHU and is involved in innovative program on biomarker discovery and detection using mass spectrometry and biochips. He has a long experience in national and international program as coordinator and partner of French and EU programs.  He is a vice-president of the “Société Française de Biologie Clinique”(SFBC) in charge of its Scientific Committee, is a member of the Working Group “CSF proteins” of the International federation of clinical chemistry and laboratory medicine (IFCC) and is the head of the Montpellier Center of Excellence in Neurodegenerative Diseases ( Prof Lehmann is member of the Editorial Board of the Journal Clinical Chemistry and Laboratory Medicine (CCLM) also the Cofounder of the Start-up Spot-To-Lab Specialized in biological diagnosis and innovation using dry blood spots ( WEB professional profiles and links : Linkedin ProfileFrontiers ProfileGoogle Scholar

Contact: CHU of Montpellier, IRMB, 80 av. Fliche, 34295 Montpellier, France